Present market dynamics and foreseeable headwinds cast a shadow over its short-term prospects, and we have little optimism for a...
Read moreEliem Therapeutics, Inc. is a clinical-stage biotechnology company, deeply rooted in the mission of advancing therapies tailored for neuronal excitability...
Read moreApplied UV Inc. (NASDAQ: AUVI), a key player in the realm of proprietary surface and air disinfection technology spanning multiple...
Read moreThorne HealthTech (NASDAQ:THRN) is exploring a sale of the company which could possibly make it an interesting short term investment...
Read moreSince our previous coverage, CN Energy has achieved compelling and noteworthy milestones in addition to impressive financial gains, making it...
Read morePollo Tropical is poised to be acquired by Authentic Restaurant Brands (ARB) for a staggering $225 million i.e., $8.50 per...
Read moreRenowned trucking company Yellow Corp (NASDAQ:YELL), with a near-century history, has recently announced its closure. The company was once prominent...
Read moreSmall cap stocks are on the up and up lately. Cheaper than their larger counterparts and often outperforming them as...
Read moreHomeStreet Bank, a Seattle-based micro-cap lender that focuses on mortgages and commercial real estate loans, is exploring a potential sale.
Read moreMuscle Maker Inc. (Nasdaq: GRIL) has made a pivot unlike any other, and effective, July 27, 2023, the Company will...
Read moreThese Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.
CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE
To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.
If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.